About PointCross
PointCross is a Healthcare company based in Foster City (United States) founded in 2000. Big data platform desktop software for preclinical clinical research regulatory applications. PointCross has raised $120 thousand across 2 funding rounds. The company has 109 employees. Its Indian entity Pointcross .Com Private Limited reported revenue of ₹26.93 Cr. PointCross offers products and services including XBIOM™ Solutions Platform, XBIOM™ VDR, XBIOM™ MDR, XBIOM™ UDM, and eDataValidator. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and In SIlico Assays. Its competitors include Cellumen, Conifer Point and IOTA Pharma; 1 of its 3 listed competitors has raised funding.
Company details
PointCross Life Sciences provides technologies to support drug safety development through a suite of Nonclinical and Clinical offerings These include safety biomarker detection and analytics, data validation, regulatory reviews, submissions support, and study data conversion services. Its clients include global BioPharma companies as well as the FDA. It has developed the Xbiom Platform MySEND software. MySEND is a free, downloadable personal desktop toolbox for nonclinical data sets validation, review, and visualization. It allows the user to view data as tabulations, interactive graphics with charts, or through the advanced histopathology viewers. Xbiom is the big data platform tailored to both nonclinical and clinical industry needs in the areas of research and regulatory submission. It has different versions such as Xbiom Insights Clinical Biomarker, Xbiom Insights Nonclinical, Xbiom Regulatory Clinical Nonclinical.
- Headquarters Foster City, United States
- Employees 109
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pointcrosslifesciences.com
- Social LinkedIn X Facebook YouTube
- Legal Name Pointcross .Com Private Limited
- Date of Incorporation 16 Mar, 2000
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹26.93 Cr
FY 2025 · +22% YoY
- Indian entity net profit₹2.19 Cr
FY 2025 · 8% margin
- Indian entity EBITDA₹3.15 Cr
FY 2025 · 12% margin
- Total Equity Funding$120K (USD)
in 2 rounds
- Latest Funding Round$60K (USD), Seed
Jun 2007
- Employee Count109
Associated legal entities of PointCross
PointCross operates through Pointcross .Com Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pointcross .Com Private Limited CIN U72900KA2000PTC026637 | Active | 16 Mar 2000 | Bangalore, Karnataka | ₹26.9 Cr | 109 | 3 | View details |
Products & Services of PointCross
PointCross offers a comprehensive portfolio of products and services, including XBIOM™ Solutions Platform, XBIOM™ VDR, XBIOM™ MDR, XBIOM™ UDM, and eDataValidator.
Platform for ingesting and curating clinical study data.
Handles exchange of study data from various sources.
Automates transformation and standardization of data.
Provides universal data model for querying and storage.
Ensures compliance and quality in clinical data sets.
Apps and channels of PointCross
its YouTube channel PointCross Life Sciences has 97 subscribers and 30 videos.
Videos from PointCross
The most watched videos on PointCross's YouTube channel, PointCross Life Sciences (97 subscribers). Click a video to play it here.
More on PointCross Life Sciences.
Funding Insights of PointCross
PointCross has successfully raised a total of $120K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $60 thousand completed in June 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $120,000
- Total Rounds 2
- Last Round Seed — $60,000
- First Round $60,000
(Feb 2007)
All 2 funding rounds of PointCross with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | $60,000 | Seed | – | – | – |
| Feb 2007 | $60,000 | Seed | – | – | – |
Board of directors of Pointcross .Com Private Limited (PointCross)
Pointcross .Com Private Limited is the primary company behind PointCross. The board of Pointcross .Com Private Limited currently have 3 directors; the longest-serving is Sukumar Rangachari, appointed in 2000. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sukumar Rangachari DIN 00374527 | Director | 16 Jun 2000 | 26 yrs 4 mo | Pointcross .Com Private Limited |
| Suresh Madhavan DIN 00401766 | Director | 26 Dec 2000 | 25 yrs 9 mo | Pointcross .Com Private Limited |
| Ashok Radhakrishna Kamath DIN 00401596 | Director | 16 Jul 2001 | 25 yrs 3 mo | Pointcross .Com Private Limited |
Financials of PointCross
Figures of Pointcross .Com Private Limited, the primary company behind PointCross, for FY 2025. Revenue was ₹26.93 Cr (+22% year on year). Net profit was ₹2.19 Cr (8% margin). EBITDA was ₹3.15 Cr (12% margin). Revenue has grown at a compounded annual rate of +16% over three years and +11% over five years.
- ₹26.93 CrRevenue · FY 2025 · +22% YoY
- ₹2.19 CrNet profit · 8% margin
- ₹3.15 CrEBITDA · 12% margin
- ₹5 LakhPaid-up capital
- 109Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pointcross .Com Private Limited are on its company page.
Detailed financial statements for PointCross
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PointCross
3 dated milestones of PointCross across 7 years, from founding to its latest funding, stage changes and deals.
- Founded PointCross is founded.
- Funding First funding round of $60K.
- Funding Latest funding round, Seed, of $60K.
Competitors of PointCross
PointCross has 3 listed competitors in our database, 1 of them funded. They include Cellumen, Conifer Point and IOTA Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellumen.com | 2004 | Pittsburgh, United States | $11.43M | Systems biology solutions for drug safety and efficacy are provided. | ||
| coniferpoint.com | 2015 | Doylestown, United States | New drugs are developed using custom fragment-based design software. | |||
| iotapharma.com | 2007 | Cambridge, United States | Offers fragment-based drug discovery products and services. |
Detailed competitors of PointCross
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PointCross
The website of PointCross (pointcrosslifesciences.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 97.9% vs previous month
Websites whose visitors overlap most with PointCross. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.co.in | 100% | 77M | #407 | View details | |
mndresearch.blog | mndresearch.blog | 94% | #1,572,988 | – | |
| therqa.com | 80% | #1,836,160 | View details | ||
plengegen.com | plengegen.com | 77% | #3,994,240 | – | |
| asphalion.com | 73% | 4.9K | #3,980,013 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for PointCross
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as PointCross (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pointcross
Complete news archive for PointCross
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PointCross
PointCross was founded in 2000 and raised its 1st funding round 7 years after it was founded.
PointCross is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
PointCross is a funded company, having raised a total of $120K across 2 funding rounds to date. The company's 1st funding round was a Seed of $60K, raised on Feb 2007.
PointCross has 109 employees.
The primary company behind PointCross, Pointcross .Com Private Limited, reported revenue of ₹26.93 Cr for FY 2025, up 22% year on year.
PointCross Life Sciences provides technologies to support drug safety development through a suite of Nonclinical and Clinical offerings These include safety biomarker detection and analytics, data validation, regulatory reviews, submissions support, and study data conversion services. Its clients include global BioPharma companies as well as the FDA. It has developed the Xbiom Platform MySEND software. MySEND is a free, downloadable personal desktop toolbox for nonclinical data sets validation, review, and visualization. It allows the user to view data as tabulations, interactive graphics with charts, or through the advanced histopathology viewers. Xbiom is the big data platform tailored to both nonclinical and clinical industry needs in the areas of research and regulatory submission. It has different versions such as Xbiom Insights Clinical Biomarker, Xbiom Insights Nonclinical, Xbiom Regulatory Clinical Nonclinical.
PointCross's top competitors include Cellumen, Conifer Point and IOTA Pharma.
PointCross offers XBIOMâ„¢ Solutions Platform, XBIOMâ„¢ VDR, XBIOMâ„¢ MDR, XBIOMâ„¢ UDM, and eDataValidator.
PointCross operates through Pointcross .Com Private Limited.
The legal entities of PointCross currently have 3 directors, including Ashok Radhakrishna Kamath, Suresh Madhavan, Sukumar Rangachari.